Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
N Engl J Med
    September 2021
  1. NEILAN AM, Salvant Valentine S, Knopf AS
    Case 27-2021: A 16-Year-Old Boy Seeking Human Immunodeficiency Virus Prophylaxis.
    N Engl J Med. 2021;385:1034-1041.
    >> Share

    August 2021
  2. PURUSHOTHAMAN S, Mayakuntla B
    Circinate Syphilitic Lesions.
    N Engl J Med. 2021;385:e26.
    >> Share

  3. ABDOOL KARIM Q
    Enhancing HIV Prevention with Injectable Preexposure Prophylaxis.
    N Engl J Med. 2021;385:652-653.
    >> Share

  4. LANDOVITZ RJ, Donnell D, Clement ME, Hanscom B, et al
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
    N Engl J Med. 2021;385:595-608.
    >> Share

  5. GOLDSTEIN RH, Mehan WA, Hutchison B, Robbins GK, et al
    Case 24-2021: A 63-Year-Old Woman with Fever, Sore Throat, and Confusion.
    N Engl J Med. 2021;385:641-648.
    >> Share

  6. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    >> Share

    July 2021
  7. PATON NI, Musaazi J, Kityo C, Walimbwa S, et al
    Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
    N Engl J Med. 2021;385:330-341.
    >> Share

    June 2021
  8. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    >> Share

  9. TSENG ZH, Moffatt E, Kim A, Vittinghoff E, et al
    Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV.
    N Engl J Med. 2021;384:2306-2316.
    >> Share

  10. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;384:2131-2143.
    >> Share

    May 2021
  11. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    >> Share

  12. DORMAN SE, Nahid P, Kurbatova EV, Phillips PPJ, et al
    Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
    N Engl J Med. 2021;384:1705-1718.
    >> Share

  13. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    >> Share

    April 2021
  14. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    >> Share

  15. NORASETHASOPON T, Boonyagars L
    Talaromycosis.
    N Engl J Med. 2021;384:1261.
    >> Share

    March 2021
  16. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    >> Share

  17. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    >> Share

  18. FEINBERG MB
    Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    N Engl J Med. 2021;384:1157-1159.
    >> Share

  19. GRAY GE, Bekker LG, Laher F, Malahleha M, et al
    Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
    N Engl J Med. 2021;384:1089-1100.
    >> Share

  20. WALKER BD
    The AMP Trials - A Glass Half Full.
    N Engl J Med. 2021;384:1068-1069.
    >> Share

  21. COREY L, Gilbert PB, Juraska M, Montefiori DC, et al
    Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
    N Engl J Med. 2021;384:1003-1014.
    >> Share

  22. THAMMAVARANUCUPT K, Spanuchart I
    Sulfonamide Crystals.
    N Engl J Med. 2021;384:1053.
    >> Share

  23. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    >> Share

    December 2020
  24. HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
    Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
    N Engl J Med. 2020;383:2572-2580.
    >> Share

  25. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    >> Share

  26. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
    >> Share

    November 2020
  27. MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
    >> Share

    October 2020
  28. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    >> Share

  29. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
    >> Share

    September 2020
  30. GANDHI M, Rutherford GW
    Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
    >> Share

    August 2020
  31. GOTTLIEB GS, Rosenberg JM, Gonzalez RG, Gandhi RT, et al
    Case 27-2020: A 53-Year-Old Woman with Headache and Gait Imbalance.
    N Engl J Med. 2020;383:859-866.
    >> Share

  32. CHAMBERS HF, Bayer AS
    Native-Valve Infective Endocarditis.
    N Engl J Med. 2020;383:567-576.
    >> Share

    July 2020
  33. MADHI SA, Polack FP, Piedra PA, Munoz FM, et al
    Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
    N Engl J Med. 2020;383:426-439.
    >> Share

  34. REGHUKUMAR A, Benson R
    Burning Pain in the Legs.
    N Engl J Med. 2020;383:e18.
    >> Share

  35. GINSBURG AS, Mvalo T, Nkwopara E, McCollum ED, et al
    Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
    N Engl J Med. 2020;383:13-23.
    >> Share

  36. FAUCI AS, Lane HC
    Four Decades of HIV/AIDS - Much Accomplished, Much to Do.
    N Engl J Med. 2020;383:1-4.
    >> Share

  37. DZAU VJ, Fineberg HV, Shine KI, Thier SO, et al
    A Half-Century of Progress in Health - A Perspective Series in Honor of the 50th Anniversary of the National Academy of Medicine.
    N Engl J Med. 2020;383:76-77.
    >> Share

    June 2020
  38. CHAISSON RE
    Empirical Antituberculosis Therapy in Advanced HIV Disease - Too Much, Too Late.
    N Engl J Med. 2020;382:2459-2460.
    >> Share

  39. BLANC FX, Badje AD, Bonnet M, Gabillard D, et al
    Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
    N Engl J Med. 2020;382:2397-2410.
    >> Share

  40. NIMMO C, Naidoo K, O'Donnell M
    Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
    N Engl J Med. 2020;382:2376.
    >> Share

    May 2020
  41. GELERIS J, Sun Y, Platt J, Zucker J, et al
    Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 May 7. doi: 10.1056/NEJMoa2012410.
    >> Share

    April 2020
  42. SAFER JD, Tangpricha V
    Care of Transgender Persons. Reply.
    N Engl J Med. 2020;382:1482.
    >> Share

  43. RHAME F, Weinlaeder A
    Care of Transgender Persons.
    N Engl J Med. 2020;382:1482.
    >> Share

  44. ADELEYE A, Lengyel E
    Care of Transgender Persons.
    N Engl J Med. 2020;382:1481-1482.
    >> Share

  45. LOMBARDO J, Simone N
    Care of Transgender Persons.
    N Engl J Med. 2020;382:1481.
    >> Share

  46. ZAHEEN A, Bloom BR
    Tuberculosis in 2020 - New Approaches to a Continuing Global Health Crisis.
    N Engl J Med. 2020;382:e26.
    >> Share

    March 2020
  47. KOZAL M, Aberg J, Pialoux G, Cahn P, et al
    Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2020;382:1232-1243.
    >> Share

  48. GUPTA A, Montepiedra G, Theron G
    HIV, Pregnancy, and Isoniazid Preventive Therapy. Reply.
    N Engl J Med. 2020;382:1184-1185.
    >> Share

  49. TIENDREBEOGO T, Anglaret X, Becquet R
    HIV, Pregnancy, and Isoniazid Preventive Therapy.
    N Engl J Med. 2020;382:1184.
    >> Share

  50. GRANDI V, De Francesco I
    Penile Kaposi's Sarcoma.
    N Engl J Med. 2020;382:e20.
    >> Share

  51. CURRIER JS
    Monthly Injectable Antiretroviral Therapy - Version 1.0 of a New Treatment Approach.
    N Engl J Med. 2020;382:1164-1165.
    >> Share

  52. MASSOTH LR, Louissaint A Jr
    Massive Splenomegaly from Disseminated Mycobacterium avium-intracellulare Infection.
    N Engl J Med. 2020;382:1041.
    >> Share

  53. CONRADIE F, Diacon AH, Ngubane N, Howell P, et al
    Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
    N Engl J Med. 2020;382:893-902.
    >> Share

  54. SWINDELLS S, Andrade-Villanueva JF, Richmond GJ, Rizzardini G, et al
    Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
    N Engl J Med. 2020 Mar 4. doi: 10.1056/NEJMoa1904398.
    >> Share

  55. ORKIN C, Arasteh K, Hernandez-Mora MG, Pokrovsky V, et al
    Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
    N Engl J Med. 2020 Mar 4. doi: 10.1056/NEJMoa1909512.
    >> Share

    February 2020
  56. THOMAS J, Govender N, McCarthy KM, Erasmus LK, et al
    Outbreak of Listeriosis in South Africa Associated with Processed Meat.
    N Engl J Med. 2020;382:632-643.
    >> Share

    January 2020
  57. BLASI M, Stadtler H, Chang J, Hemmersbach-Miller M, et al
    Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
    N Engl J Med. 2020;382:195-197.
    >> Share

    December 2019
  58. ARMSTRONG GL, MacCannell DR, Taylor J, Carleton HA, et al
    Pathogen Genomics in Public Health.
    N Engl J Med. 2019;381:2569-2580.
    >> Share

  59. DEOL AK, Fleming FM, Calvo-Urbano B, Walker M, et al
    Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
    N Engl J Med. 2019;381:2519-2528.
    >> Share

  60. GOLDSTEIN RH, Walensky RP
    Gender Parity in Clinical PrEP Trials. Reply.
    N Engl J Med. 2019;381:2585-2586.
    >> Share

  61. BRAINARD DM, McCallister S
    Gender Parity in Clinical PrEP Trials.
    N Engl J Med. 2019;381:2585.
    >> Share

  62. MURRAY J, Birnkrant D
    Gender Parity in Clinical PrEP Trials.
    N Engl J Med. 2019;381:2584-2585.
    >> Share

  63. HOTEZ PJ, Engels D, Gyapong M, Ducker C, et al
    Female Genital Schistosomiasis.
    N Engl J Med. 2019;381:2493-2495.
    >> Share

  64. GOLDSTEIN RH, Walensky RP
    Where Were the Women? Gender Parity in Clinical Trials.
    N Engl J Med. 2019;381:2491-2493.
    >> Share

  65. KREUTZ-RODRIGUES L, Bakri K
    Tenosynovitis Due to Mycobacterium avium Complex.
    N Engl J Med. 2019;381:2461.
    >> Share

    November 2019
  66. LOCKMAN S, Makhema J, Essex M
    Universal Testing and Treatment for HIV Infection in Botswana. Reply.
    N Engl J Med. 2019;381:2180.
    >> Share

  67. VALDANO E, Blower S
    Universal Testing and Treatment for HIV Infection in Botswana.
    N Engl J Med. 2019;381:2180.
    >> Share

  68. KAZI DS, Katz IT, Jha AK
    PrEParing to End the HIV Epidemic - California's Route as a Road Map for the United States.
    N Engl J Med. 2019 Nov 27. doi: 10.1056/NEJMp1912293.
    >> Share

  69. SAAG M, Mendoza DP, Sherman MS, Cote GM, et al
    Case 36-2019: A 34-Year-Old Man with Dyspnea, Odynophagia, and Abdominal Pain.
    N Engl J Med. 2019;381:2052-2061.
    >> Share

  70. DE COCK KM, Zielinski-Gutierrez E, Lucas SB
    Learning from the Dead.
    N Engl J Med. 2019;381:1889-1891.
    >> Share

    October 2019
  71. TAIT DR, Hatherill M, Van Der Meeren O, Ginsberg AM, et al
    Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2019 Oct 29. doi: 10.1056/NEJMoa1909953.
    >> Share

  72. SELHORST P, Combrinck CE, Manning K, Botha FCJ, et al
    Longer-Term Outcomes of HIV-Positive-to-HIV-Positive Renal Transplantation.
    N Engl J Med. 2019;381:1387-1389.
    >> Share

  73. GUPTA A, Montepiedra G, Aaron L, Theron G, et al
    Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.
    N Engl J Med. 2019;381:1333-1346.
    >> Share

    September 2019
  74. CHAISSON RE, Ramchandani R, Swindells S
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.
    N Engl J Med. 2019;381:e23.
    >> Share

  75. STOUT JE, Sterling TR, Horsburgh CR Jr
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
    N Engl J Med. 2019;381:e23.
    >> Share

  76. JUNE CH
    Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure.
    N Engl J Med. 2019 Sep 11. doi: 10.1056/NEJMe1910754.
    >> Share

  77. XU L, Wang J, Liu Y, Xie L, et al
    CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
    N Engl J Med. 2019 Sep 11. doi: 10.1056/NEJMoa1817426.
    >> Share

    August 2019
  78. LUBKE N, Jensen B, Huttig F, Feldt T, et al
    Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R.
    N Engl J Med. 2019;381:887-889.
    >> Share

  79. RAESIMA MM, Ogbuabo CM, Thomas V, Forhan SE, et al
    Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.
    N Engl J Med. 2019;381:885-887.
    >> Share

    July 2019
  80. DENTALE N, Trisolini R
    Respiratory Papillomatosis.
    N Engl J Med. 2019;381:358.
    >> Share

  81. VENTER WDF, Moorhouse M, Sokhela S, Fairlie L, et al
    Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1902824.
    >> Share


  82. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1904340.
    >> Share

  83. HAVLIR DV, Doherty MC
    Global HIV Treatment - Turning Headwinds to Tailwinds.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMe1909363.
    >> Share

  84. REDFIELD RR, Modi S, Moore CA, Delaney A, et al
    Health Care Autonomy of Women Living with HIV.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMp1908843.
    >> Share

  85. ZASH R, Holmes L, Diseko M, Jacobson DL, et al
    Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
    N Engl J Med. 2019 Jul 22. doi: 10.1056/NEJMoa1905230.
    >> Share

  86. ABDOOL KARIM SS
    HIV-1 Epidemic Control - Insights from Test-and-Treat Trials.
    N Engl J Med. 2019;381:286-288.
    >> Share

  87. MAKHEMA J, Wirth KE, Pretorius Holme M, Gaolathe T, et al
    Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
    N Engl J Med. 2019;381:230-242.
    >> Share

  88. HAVLIR DV, Balzer LB, Charlebois ED, Clark TD, et al
    HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.
    N Engl J Med. 2019;381:219-229.
    >> Share

  89. HAYES RJ, Donnell D, Floyd S, Mandla N, et al
    Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    N Engl J Med. 2019;381:207-218.
    >> Share

    June 2019
  90. MYERS RA, Zmarlicka MT
    Disseminated Coccidioidomycosis.
    N Engl J Med. 2019;380:e44.
    >> Share

    May 2019
  91. EL-SADR WM, Mayer KH, Rabkin M, Hodder SL, et al
    AIDS in America - Back in the Headlines at Long Last.
    N Engl J Med. 2019;380:1985-1987.
    >> Share

  92. KISHORE S, Hayden M, Rich J
    Lessons from Scott County - Progress or Paralysis on Harm Reduction?
    N Engl J Med. 2019;380:1988-1990.
    >> Share

    April 2019
  93. WANG CY, Wong WW, Tsai HC, Chen YH, et al
    Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
    N Engl J Med. 2019;380:1535-1545.
    >> Share

  94. WOJCIECHOWSKI D, Gandhi RT, Rosales IA
    Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.
    N Engl J Med. 2019;380:1464-1472.
    >> Share

    March 2019
  95. SAUNDERS MJ, Evans CA
    Ending Tuberculosis through Prevention.
    N Engl J Med. 2019;380:1073-1074.
    >> Share

  96. SWINDELLS S, Ramchandani R, Gupta A, Benson CA, et al
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
    N Engl J Med. 2019;380:1001-1011.
    >> Share

  97. SEVESTRE J, Hasseine L
    Disseminated Histoplasmosis.
    N Engl J Med. 2019;380:e13.
    >> Share

  98. NUNN AJ, Phillips PPJ, Meredith SK, Chiang CY, et al
    A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2019 Mar 13. doi: 10.1056/NEJMoa1811867.
    >> Share

    February 2019
  99. MARCUS JL, Katz KA, Krakower DS, Calabrese SK, et al
    Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis.
    N Engl J Med. 2019;380:510-512.
    >> Share

  100. BEN-CHETRIT E, Shavit L, Tvito A, Korem M, et al
    The Devil Is in the Details.
    N Engl J Med. 2019;380:581-586.
    >> Share

    January 2019

  101. Facing Opioids in the Shadow of the HIV Epidemic.
    N Engl J Med. 2019;380:402.
    >> Share

  102. PARKER CM, Hirsch JS, Hansen HB, Branas C, et al
    Facing Opioids in the Shadow of the HIV Epidemic.
    N Engl J Med. 2019;380:1-3.
    >> Share

  103. BOWLES AA, Smirnov B
    Erythrodermic Psoriasis and HIV Infection.
    N Engl J Med. 2019;380:80.
    >> Share

    December 2018
  104. WANG HH, Lin WR
    Amebic Liver Abscess.
    N Engl J Med. 2018;379:2255.
    >> Share

    November 2018
  105. MORA CARPIO AL, Stempel JM
    Pneumococcal Bacteremia and Meningitis.
    N Engl J Med. 2018;379:2063.
    >> Share

  106. MEINTJES G, Stek C, Blumenthal L, Thienemann F, et al
    Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    N Engl J Med. 2018;379:1915-1925.
    >> Share

  107. BLANK S, Daskalakis DC
    Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment Options.
    N Engl J Med. 2018;379:1795-1797.
    >> Share

    October 2018
  108. MUFTUOGLU M, Olson A, Marin D, Ahmed S, et al
    Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    N Engl J Med. 2018;379:1443-1451.
    >> Share

    September 2018
  109. VAN DER MEEREN O, Hatherill M, Nduba V, Wilkinson RJ, et al
    Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMoa1803484.
    >> Share

  110. GOLDSTEIN RH, Streed CG Jr, Cahill SR
    Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    N Engl J Med. 2018 Sep 19. doi: 10.1056/NEJMp1804306.
    >> Share

  111. ZASH R, Makhema J, Shapiro RL
    Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    N Engl J Med. 2018;379:979-981.
    >> Share

    August 2018
  112. EMU B, Fessel J, Schrader S, Kumar P, et al
    Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
    N Engl J Med. 2018;379:645-654.
    >> Share

  113. SHEIKH V, Murray JS, Sherwat A
    Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty.
    N Engl J Med. 2018;379:605-607.
    >> Share

  114. SHAH NN, Singavi AK, Harrington A
    Daratumumab in Primary Effusion Lymphoma.
    N Engl J Med. 2018;379:689-690.
    >> Share

    July 2018
  115. HONIGBERG MC, Westlake AA, Griffin GK, Vaidya A, et al
    A Lump in the Neck.
    N Engl J Med. 2018;379:e8.
    >> Share

  116. RECIO R, Perez-Ayala A
    Cryptococcus neoformans Meningoencephalitis.
    N Engl J Med. 2018;379:281.
    >> Share

  117. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
    Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    N Engl J Med. 2018;379:138-149.
    >> Share

    June 2018

  118. Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMx180021.
    >> Share

  119. MULASI I
    The Scarlet Virus.
    N Engl J Med. 2018;378:2157-2159.
    >> Share

    May 2018
  120. ZUCMAN D, Mellot F, Couderc L
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-5.
    >> Share

  121. CHAMSEDDINE AN, Loulergue P, Mir O
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144.
    >> Share


  122. HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-2145.
    >> Share

  123. JUSTMAN JE, Mugurungi O, El-Sadr WM
    HIV Population Surveys - Bringing Precision to the Global Response.
    N Engl J Med. 2018;378:1859-1861.
    >> Share

  124. FARIA D, Freitas A
    Tuberculous Pericarditis.
    N Engl J Med. 2018;378:e27.
    >> Share

  125. ZUGER A
    Moving On.
    N Engl J Med. 2018;378:1763-1765.
    >> Share

  126. GOMEZ CA, Banaei N
    Trypanosoma cruzi Reactivation in the Brain.
    N Engl J Med. 2018;378:1824.
    >> Share

    April 2018
  127. BACK DJ
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654-5.
    >> Share

  128. SANDRONI S
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654.
    >> Share

  129. ROUGH K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, et al
    Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    N Engl J Med. 2018;378:1593-1603.
    >> Share


  130. Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1655-6.
    >> Share

  131. FELDMANN H
    Virus in Semen and the Risk of Sexual Transmission.
    N Engl J Med. 2018;378:1440-1441.
    >> Share

  132. MEAD PS, Duggal NK, Hook SA, Delorey M, et al
    Zika Virus Shedding in Semen of Symptomatic Infected Men.
    N Engl J Med. 2018;378:1377-1385.
    >> Share

    March 2018
  133. YANG YT, Underhill K
    Rethinking Criminalization of HIV Exposure - Lessons from California's New Legislation.
    N Engl J Med. 2018;378:1174-1175.
    >> Share

  134. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    >> Share

  135. YARCHOAN R, Uldrick TS
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:1029-1041.
    >> Share

  136. MOLLOY SF, Kanyama C, Heyderman RS, Loyse A, et al
    Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
    N Engl J Med. 2018;378:1004-1017.
    >> Share


  137. HIV Drug Resistance.
    N Engl J Med. 2018;378:873-875.
    >> Share

  138. GOTTLIEB GS, Raugi DN, Smith RA
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874-5.
    >> Share

  139. BERTAGNOLIO S, Jordan MR, Doherty M
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874.
    >> Share

  140. INZAULE SC, Rinke de Wit TF, Hamers RL
    HIV Drug Resistance.
    N Engl J Med. 2018;378:873-4.
    >> Share

    February 2018
  141. AHUKA-MUNDEKE S, Casey RM, Harris JB, Dixon MG, et al
    Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report.
    N Engl J Med. 2018 Feb 14. doi: 10.1056/NEJMoa1710430.
    >> Share

    January 2018
  142. MARTIN EG, Schackman BR
    Treating and Preventing HIV with Generic Drugs - Barriers in the United States.
    N Engl J Med. 2018;378:316-319.
    >> Share

  143. FAUCI AS, Eisinger RW
    PEPFAR - 15 Years and Counting the Lives Saved.
    N Engl J Med. 2018;378:314-316.
    >> Share

  144. MARGOLIS DM, Garcia JV
    Countering HIV - Three's the Charm?
    N Engl J Med. 2018;378:295-297.
    >> Share

    December 2017
  145. SI Z, Qiao J
    Talaromyces marneffei Infection.
    N Engl J Med. 2017;377:2580.
    >> Share

  146. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    >> Share

    November 2017
  147. GRABOWSKI MK, Serwadda DM, Gray RH, Nakigozi G, et al
    HIV Prevention Efforts and Incidence of HIV in Uganda.
    N Engl J Med. 2017;377:2154-2166.
    >> Share

  148. GOMEZ-MOYANO E, Crespo-Erchiga V
    HIV Infection Manifesting as Proximal White Onychomycosis.
    N Engl J Med. 2017;377:e26.
    >> Share

    October 2017
  149. BEYRER C, Pozniak A
    HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    N Engl J Med. 2017;377:1605-1607.
    >> Share

  150. KENNEDY SB, Bolay F, Kieh M, Grandits G, et al
    Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
    N Engl J Med. 2017;377:1438-1447.
    >> Share

    September 2017
  151. RICHARDSON HS, Eyal N, Campbell JI, Haberer JE, et al
    When Ancillary Care Clashes with Study Aims.
    N Engl J Med. 2017;377:1213-1215.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016